Infection Control Market Supported by Growing Demand for Non-Woven Disposable Products, Surface Disinfection Solutions, Sterilization Technologies, and Expanding Healthcare Infrastructure to Register 6.5% CAGR Growth Through 2036

NEWARK, DE / ACCESS Newswire / May 25, 2026 / According to the latest market analysis by Future Market Insights (FMI), the infection control market is entering a sustained growth phase as healthcare providers, diagnostic laboratories, hospitals, and institutional care facilities increasingly prioritize patient safety, treatment standardization, and regulatory-compliant infection prevention protocols across global healthcare systems.

The market, valued at USD 242.04 billion in 2025, is projected to reach USD 517.98 billion by 2036, registering a CAGR of 6.5% during the forecast period. Growth is being supported by tightening infection prevention regulations, increasing procedural volumes, expanding healthcare infrastructure, and rising institutional demand for validated sterilization and disinfection solutions across clinical environments.

Infection control solutions are evolving from standard consumable products into strategically essential healthcare systems supporting patient safety, hospital hygiene compliance, surface disinfection, surgical sterilization, and outbreak prevention initiatives worldwide.

Get detailed market forecasts, competitive benchmarking, and pricing trends:
https://www.futuremarketinsights.com/reports/sample/rep-gb-391

Summary of Infection Control Market

• Market Size (2026): USD 242.04 Billion

• Market Size (2036): USD 517.98 Billion

• Growth Rate: 6.5% CAGR (2026-2036)

• Leading Product Segment: Non-Woven Disposable (39.2% share)

• Leading Application Segment: Surface Disinfection (58.9% share)

• Leading End User Segment: Diagnostic Laboratories (30.6% share)

• Incremental Opportunity: USD 242.04 Billion

• Key Growth Regions: China, India, Germany, France, United Kingdom, USA

• Key Players: Nordion Inc., Johnson & Johnson Private Limited, BELIMED INC., Getinge AB., Medivators Inc., Kimberly-Clark Corporation, CISA Group, STERIS, Ecolab, Advanced Sterilization Products

Rising Demand for Infection Prevention and Regulatory Compliance Reshaping the Infection Control Industry

The infection control market is witnessing strong momentum as healthcare providers increasingly depend on sterilization systems, surface disinfection products, surgical infection prevention solutions, and disposable clinical products to maintain hygiene standards and reduce healthcare-associated infection risks.

Vendors are increasingly focusing on:

• Expanding non-woven disposable and sterilization equipment portfolios

• Supporting institutional infection prevention and patient safety protocols

• Enhancing product validation and regulatory compliance capabilities

• Improving operational efficiency through standardized infection control systems

• Strengthening manufacturing scalability and supply chain resilience

This transition reflects broader healthcare industry demand for dependable infection prevention systems that combine clinical efficacy, regulatory compliance, operational reliability, and cost-efficient procurement strategies.

Product and Segment Trends

Market segmentation highlights strong demand for institutional-grade infection control solutions:

• Non-woven disposable products (39.2%) lead product demand due to widespread use in hospitals, laboratories, and outpatient facilities

• Surface disinfection applications (58.9%) dominate market demand because healthcare facilities continue prioritizing hygiene protocol standardization

• Diagnostic laboratories (30.6%) lead end-user demand through high-frequency testing procedures and contamination control requirements

• Sterilization equipment continues gaining adoption as hospitals modernize infection prevention infrastructure

• Disinfection equipment demand is increasing as healthcare systems focus on procedural safety and clinical compliance

Infection control products are increasingly becoming central to hospital hygiene management, surgical safety, contamination reduction, and regulatory-driven procurement systems.

Speak to Analyst: Customize insights for your business strategy:
https://www.futuremarketinsights.com/customization-available/rep-gb-391

Regulatory Compliance and Institutional Procurement Driving Innovation

Infection control manufacturers are prioritizing:

• Advanced sterilization validation technologies

• Regulatory-compliant disinfection systems and workflow integration

• Improved non-woven disposable materials supporting procedural safety

• Scalable manufacturing and institutional supply continuity

• Product traceability and quality assurance documentation systems

Innovation is increasingly focused on balancing clinical effectiveness, procurement efficiency, operational scalability, and regulatory compliance across healthcare ecosystems.

Diagnostic Laboratories and Healthcare Infrastructure Expansion Driving Value Creation

Healthcare suppliers are differentiating through:

• Expansion of infection prevention product portfolios

• Strengthening institutional procurement and distribution partnerships

• Supporting hospital hygiene modernization initiatives

• Developing scalable sterilization and disinfection technologies

• Enhancing regulatory support and clinical validation services

Companies capable of combining product quality, regulatory expertise, scalable manufacturing, and dependable institutional supply are gaining competitive advantage across global healthcare markets.

Supply Chain and Deployment Trends

The market is witnessing increased investment in manufacturing scalability and supply reliability, including:

• Expansion of sterilization and disinfection equipment manufacturing capacity

• Greater focus on regional manufacturing localization strategies

• Increased investment in validated infection prevention technologies

• Stronger emphasis on quality management and regulatory traceability

• Improved institutional procurement and supply continuity programs

These strategies are helping suppliers improve customer retention, institutional standardization opportunities, and long-term procurement relationships.

Explore the Latest Healthcare Industry Analysis Now:
https://www.futuremarketinsights.com/industry-analysis/healthcare

Regional Outlook and Growth Opportunities

The market demonstrates strong regional growth trends:

• China (8.8% CAGR): Large-scale healthcare infrastructure investment and manufacturing expansion supporting sustained infection control demand

• India (8.1% CAGR): Healthcare modernization and expanding institutional procurement accelerating product adoption

• Germany (7.5% CAGR): Regulatory modernization and industrial healthcare standards supporting premium infection control demand

• France (6.8% CAGR): Institutional procurement expansion driving standardized infection prevention adoption

• United Kingdom (6.2% CAGR): Healthcare system modernization supporting procedural disinfection and sterilization investments

• USA (5.5% CAGR): Mature healthcare infrastructure sustaining replacement demand for advanced infection control systems

The global infection control market remains a steadily expanding healthcare category as providers increasingly prioritize contamination prevention, patient safety, and standardized infection management solutions worldwide.

Buyer Trends and Enterprise Purchasing Priorities

Key buyer priorities include:

• Regulatory-compliant infection prevention systems

• Reliable sterilization and surface disinfection performance

• Institutional procurement compatibility and supply continuity

• Clinical validation and quality assurance support

• Cost-efficient long-term procurement partnerships

Healthcare buyers are increasingly prioritizing suppliers capable of delivering validated product performance, regulatory consistency, and scalable distribution capabilities.

Competitive Landscape

The infection control market remains moderately consolidated across sterilization specialists, healthcare consumables manufacturers, and institutional hygiene solution providers focusing on regulatory compliance and clinical performance.

Leading companies are focusing on:

• Expanding infection prevention and sterilization portfolios

• Strengthening institutional procurement and distribution networks

• Enhancing regulatory compliance and validation capabilities

• Supporting healthcare infrastructure modernization initiatives

• Investing in manufacturing scalability and regional expansion

Key companies include:

• Nordion Inc.

• Johnson & Johnson Private Limited

• BELIMED INC.

• Getinge AB.

• Medivators Inc.

• Kimberly-Clark Corporation

• CISA Group

• STERIS

• Ecolab

• Advanced Sterilization Products

Companies capable of combining regulatory expertise, institutional procurement support, manufacturing scalability, and validated infection prevention technologies are expected to maintain the strongest market positions.

Unlock high-growth opportunities with FMI's niche business market insights:
https://www.futuremarketinsights.com/industry-analysis

Long-Term Deployment Strategies and Customer Retention

Market participants are increasingly focusing on long-term customer retention through:

• Continuous expansion of validated infection prevention technologies

• Development of scalable sterilization and disinfection systems

• Strengthening institutional procurement and distribution agreements

• Regional manufacturing expansion and supply chain localization

• Clinical validation support and healthcare workflow integration programs

Suppliers delivering dependable product quality, regulatory compliance, institutional procurement support, and scalable infection prevention capabilities are expected to achieve stronger recurring procurement opportunities and long-term market positioning.

Related Reports

• Hospital-Acquired Infection (HAI) Control Market - https://www.futuremarketinsights.com/reports/hospital-acquired-infection-control-market

• Endoscopic Probe Disinfection Market - https://www.futuremarketinsights.com/reports/endoscopic-probe-disinfection-market

• Mosquito-borne infections Testing Market - https://www.futuremarketinsights.com/reports/mosquito-borne-infections-testing-market

• Urinary Tract Infection Testing Market - https://www.futuremarketinsights.com/reports/urinary-tract-infection-testing-market

• Intra-Abdominal Infection Treatment Market - https://www.futuremarketinsights.com/reports/intra-abdominal-infection-treatment-market

About Future Market Insights (FMI)

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. Headquartered in Delaware, USA, with a global delivery center in India and offices in the UK and UAE, FMI delivers actionable insights to businesses across industries including automotive, technology, consumer products, manufacturing, energy, and chemicals.

An ESOMAR-certified research organization, FMI provides custom and syndicated market reports and consulting services, supporting both Fortune 1,000 companies and SMEs. Its team of 300+ experienced analysts ensures credible, data-driven insights to help clients navigate global markets and identify growth opportunities.

For Press & Corporate Inquiries

Rahul Singh
AVP - Marketing and Growth Strategy
Future Market Insights, Inc.
+91 8600020075
For Sales - sales@futuremarketinsights.com
For Media - Rahul.singh@futuremarketinsights.com
For Web - https://www.futuremarketinsights.com
For Web - https://www.factmr.com

SOURCE: Future Market Insights, Inc.